|
ZMYND11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62592161956354E-12 |
| Normal-vs-Stage2 |
1.71509999979946E-07 |
| Normal-vs-Stage3 |
1.02789999956165E-07 |
| Normal-vs-Stage4 |
2.20779949877681E-10 |
| Stage1-vs-Stage2 |
7.386800E-01 |
| Stage1-vs-Stage3 |
5.931000E-01 |
| Stage1-vs-Stage4 |
2.227000E-01 |
| Stage2-vs-Stage3 |
8.948800E-01 |
| Stage2-vs-Stage4 |
2.576200E-01 |
| Stage3-vs-Stage4 |
3.797000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.86162196769146E-12 |
| Normal-vs-Asian |
7.63459999997274E-07 |
| Caucasian-vs-AfricanAmerican |
9.420000E-01 |
| Caucasian-vs-Asian |
7.574200E-01 |
| AfricanAmerican-vs-Asian |
6.868400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
6.83280000024489E-07 |
| Male-vs-Female |
6.564900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.57529989053273E-10 |
| Normal-vs-Extreme_Weight |
1.62558855265615E-12 |
| Normal-vs-Obese |
2.18559614850733E-11 |
| Normal-vs-Extreme_Obese |
1.795360E-04 |
| Normal_Weight-vs-Extreme_Weight |
8.206400E-01 |
| Normal_Weight-vs-Obese |
2.837800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.630000E-01 |
| Extreme_Weight-vs-Obese |
1.415570E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.520000E-01 |
| Obese-vs-Extreme_Obese |
1.921160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.30110424843156E-11 |
| Normal-vs-Age(41-60Yrs) |
1.0935030658743E-11 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
6.01459992921605E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.783640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.375200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.530170E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.694300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.670200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.805800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.44089209850063E-16 |
| Normal-VS-Type2 PRCC |
1.62481139653892E-12 |
| Normal-VS-KIRP CIMP |
9.49259559845927E-11 |
| Normal-VS-Unclassified PRCC |
3.78690000000237E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.198040E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.306100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.765200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.019200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.127900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.223700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.6251444634463E-12 |
| Normal-vs-N1 |
2.17226236998158E-12 |
| Normal-vs-N2 |
2.21960000046373E-07 |
| N0-vs-N1 |
7.523400E-01 |
| N0-vs-N2 |
3.824400E-01 |
| N1-vs-N2 |
2.364600E-01 |
|
|
